Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would love to see a partnership on Friday after hours. Or anytime before Prurisol results. I think that could be a big time catalyst and we would get actual trial result share price movement.
Okay. Well that sums it up!
Good luck on your new companies you will be investing in. IPIX is not for you. No hard feelings over here.
Good luck
Which one of the 18 BPs do you work for? That number caught you by surprise yesterday huh? I bet of the 18, 13 called Leo yesterday and became real sweet and puckered up all of a sudden. Game on bro - first BP to act will make billions for their shareholders. IMO.
Prurisol is very exciting to me. Psoriasis is an 8 billion dollar market and biologics are brutal, many with black box warnings if not all.
This phase 2b is an apples to apples comparison using the PASI scale. Phase 2a used the IGA scale where the 200 mg arm showed promise. So in the phase 2b the company jumped the arms to 300 and 400mg.
We know an oral drug called Otezla pulled in about 1.25 billion, and that drug set the bar at 33% PASI 75
Prurisol works quicker and has less side effects.
It also comes with the fda 505 b 2 designation. That means a quicker phase 3 and it is eligible for additional years of exclusivity. The company owns it outright and has strong patent protection. The manufacturing cost is minimal as well.
We should see data within the next 2 months.
It’s time this company moves forward and loses the childish audience and penny flippers. The board is brutal on iHub for that company.
We have done several valuations here. For B-OM and just recently Prurisol: you are correct, if everything goes well, 3 digits is minimum.
A 2018 Q1 to remember. Nasdaq by end of May. Let’s go!
I love when they start popping up. He has no clue we have all been here for 6 plus years. I know the financials like the back of my better half’s ass
Agree. Less than 90 days. BP best start trying to climb over the BP in front.
I don’t think that’s just B! I think it’s a total number for all drugs. Jmo
I would have been satisfied with 5-10
But approaching 20 really proves the interest IPIX has and can show how dedicated they are to pleasing as they have trial designs and anchoring to please the possible partners.
I’m feeling Kevetrin may surprise us soon. People here have no idea just how valuable K could be.
If anyone is looking for a possible Bio that is on the OTCBB that could potentially be ready to move to Nasdaq soon: IPIX.
They have never failed a trial.
3 extremely valuable drugs
Today the CEO shared that they have almost 20 CDAs signed.
The first partnership will unlock this companies value.
It has been really beaten down by short writers on seeking-alpha and other nefarious sites over the past 3 years and even defended themselves through a lawsuit by an ambulance chasing firm who were followers of the pos seeking alpha author.
Do your own DD. But a short term catalyst is phase 2b Oral psoriasis top line data - first quarter 2018. We are looking to beat Otezla at 33% PASI 75
Good luck!
Www.ipharminc.com
There is a partner that will take care of all of that. It’s for B-OM compassionate use - BTD in USA and Europe soon.
Today’s PR was just a flare shot. It’s not for you and I - it’s for all CDA companies. Who wants to step up?
I’ll bet we see a deal in the next 90 days. A big deal
“A typical large pharmaceutical might see 500 to 1,000 opportunities in a given therapeutic area. Only 100 or so of those will go on to non-con dential meetings and only 50 or so of those will end up going to Con dential Disclosure Agreements (CDAs) and con dential meetings.”
Fantastic update. 20 CDA’s
I’d love to see: IF IPIX has a suitor for ALL of B. That suitor has something written where they throw 10million into open market purchases for either investment or share retirement. A show of good faith and understanding IPIX has been beaten. And it’s time to rise. #NEVERTOLATE
Make the suggestion IPIX! Grow together. New partner WANTED!
And it’s cheap to manufacturer which means big margins!!!!
Another thought about K-it could be getting hot in that arena. Here is why: IPIX is having more and more eyes on their drugs by pharma. I’d say it could be a strong possibility that these top line interim results for K may make the BP that designed the trial a little anxious that more eyes may bring more eyes on K.
K has proven out this far in modulating p53. Let’s see secondary data. If good. We may see a partnership.
The more eyes on all fronts make all pipeline possibilities more valuable.
Good night
So Prurisol is a wash. Meaning n value? So what if we see Pasi 75 at 40%? Otezla made 1.2 billion
And otezla was avg 32% Pasi 75.
Groton. Results soon. And why can’t they be unbelievable? I really mean that. Please answer; WHY CANT THE 400 mg arm be unreal and blow us all away? Like a psoriasis cure? The preclinical rats showed it so why can’t the proper dosing in humans have the same outcome?
The negativity and board posts just keep that idea at bay. Many posters make it sound like this Prurisol 2a trial is nothing. Unreal
My question: why aren’t people excited and thinking this trial could show PASI 75 at 60% and maybe PASI 90 at 20%? It’s possible. That’s all I’m saying. We may have the best oral psoriasis drug in the world!
We will know soon
We assured you that the lawsuit by the Rosen Law Firm was frivolous. The court agreed. We didn’t stop there. You can believe me that our team is on top of bringing the culprits behind the attack on Cellceutix to justice.
That is not just rhetoric. I will bet my shares they fulfill this promise
Agree HT. That is one questionable trait that is missing from Leo. I have seen penny companies pay promoters and give shares once they promote to certain price. Mostly those companies have zero value and are just looking to clear CDs which is not even close to what we need....here. But I do think Leo could be doing more to promote and pump this stock back up. He’s just so black and white and professional, but it’s not good for penny stocks. He should know charts and know where/when to promote the stock to break resistance and make the next moves.
Not sure if you were here but Leo played a great game back in the day where he was doing Friday PRs for a while and it pumped up the stock a good chunk. Right now we get simple trial results, data locks, and other milestone FACTS. Few and far between.
IMO. Mgmt have a partnership near. For only tapping 42k shares in 2 plus months is very telling. My number 1 indicator to be honest.
Very very exciting times. Let’s get validation. Let’s put cash in the bank, let’s cancel the aspire agreement, let’s move to the Nasdaq. That my friend will bring new eyes and new analysts who I promise will be blown away by the pipeline and mark IPIX with. BUY signals.
I do know one eastern state author reporter who is ready to pounce on this story once the first partner is announced. They are going to make IPIX sound like a true underdog. Kinda like rocky 4 - And all the bs articles and pos reporters that tore this down and failed. All while the good team at IPIX was set out to help this world.
Great times ahead.
I’m a bull and think this. Truly.
The only people that know about this stock are on iHub. There is a mass team of posters that want this lower. I do not know who or what entity they are. But they exist and you can see that by the day after day posts. Some are dual and more identities posting positive at some points and then turn to screw with retail Mom an pop investors like me to screw with our emotions. I know of one poster and 3 of their identities using a vpn to hide network configuration.
Anyways...with that said I believe there is a major goal to take this company lower.
Now, everyone here probably has that negative gulp and nervous feeling about IPIX. Because of the well coordinated day after day “play”
If you take yourself out of this board and never read it. For example my friend who is a brilliant investor and plays a penny here and there in bio based on science and mgmt etc... he has not one once of nervousness.
He just accumulated 100k worth of shares or is in the midst of finishing his position and Prurisol is his love. After speaking with him...I almost come back to earth/reality and feel great......and then I read this board.
We are extremely undervalued imo. Ask mgmt what they think of you ever speak to them. They feel the recent BOM results alone should have this at multiples of current share price. They are biased obviously and they do know 98% more than any of us....but they also KNOW what BP thinks... so when they think it should be multiples then that’s where we should be NOW.
Throw in a partnership for the B franchise I would expect major upfront cash MAJOR MAJOR milestones for multiple indications and major royalties. Based on future estimates in these indications and market share we ideally are looking at a humira type drug.
As the drug continues to pan out I do believe 20 dollars is an easy target. That is after uplist and major institutional support.
Lol so do I. But the only news that will put this outside our buying realm is partner. I was buying at 4 bucks and I’ll buy up there again. Just not in the 20’s. Which is where a partner will take us.
No worries here. I have my better half throwing in her 10K bonus next week. Locked
I would sue the hell out of you and win. If you sold the company for 3 dollars
Let’s put you in the captains chair! For today. What direction do you want to take us? What makes the most sense?
Some examples: sell the entire Brilacidin platform for a single payment? Does that value make the most sense right now and spare you from lawsuits by investors?
Do you sub license to multiple companies? Does that make it difficult to move quick over the next years? Wait for P results and see if you can sell that outright? And then work internally on B and K? There are thousands of scenarios.
Come on captain!!! What would you do?
I agree with you and Dud in the point that a deal is what is needed. Period.
We have the back-end of financing that will allow us to raise a lot off money. I think currently just over 100 million in financing from Aspire and the shelf. However Aspire at .70 is not a good option for shareholders to tap the remaining 28 million. I agree. I believe that is why the share price does not move mountains on very positive results. Because in the back of every possible investor....when can IPIX make the jump and have the $ and resources to move many trials forward and allow the positive results to make huge MC gains? Bring the valuation to a true value!
That is when we can stop the drip and have institutional support on the stock. There will forever be shorts. We can agree, and that is good. But we need a healthy percentage of the 140 million in real long term investors hands..Baker bros etc...
My gut and to answer your question: I believe Art and Leo have their suitor. I believe they have been working with this pharma for a very long time. I believe that IPIX has made it clear on their goals and valuation proposals and those were no way in hell going to be met prior to receiving Up and OM data. But now the data is in. Now they can move forward and sign the dotted line, IMO.
My real concern is that new interested parties have come into the picture and may derail some of the long term work that IPIX and suitor 1 have accomplished over the past 2-3 years.
But competition is great and makes people move. It can also increase value in biotech...so let’s hope by Leo stating more people are interested in an already ROBUST audience is a good thing
Again read the PR- finally IPIX has the data that BP has been asking for for a long time. Inflection point.
Mega B deal in the works. It took the completion and data of OM and UP to further validate B franchise. It’s still early - big deals take a while. Hang tight.
Yes there is something wrong and Sullivan who has been actively documenting and investigating for years since Mako will hopefully have all the answers in the upcoming years. Maybe 5 years from now many will be put behind bars???? Just a hope
on a more relevant "NOW" topic - Here is some good info from the company:
"Interest in the Brilacidin Franchise—based on the breadth of its treatment potential—was notable. Strong momentum gained as a result of Brilacidin’s recent positive topline findings seen in both Inflammatory Bowel Disease (IBD) and Oral Mucositis (OM), coupled with previously successful results achieved in Acute Bacterial Skin and Skin Structure Infection (ABSSSI), has delivered a complementary cross-indication scientific anchoring for each Brilacidin indication in the Company’s pipeline.
In particular, Brilacidin-OM received an exceptional degree of attention at the San Francisco shows,(this means Bio Tech and the JP Morgan) further adding to an already robust partnering matrix. Innovation is developing Brilacidin-OM under a FDA Fast Track designation as a novel therapeutic and recently met the primary endpoint in a Phase 2 trial for preventing severe OM as well as a key secondary endpoint by delaying the onset of severe OM. Brilacidin has effectively earned a leadership position as an easily-delivered oral rinse drug candidate in OM—what many analysts predict will become a $1 billion market opportunity within the next few years.
“What must be stressed is that Brilacidin is a mature, later-stage drug candidate with platform potential. It took the recent completion of two Phase 2 trials, in IBD and OM, to further validate the exceptional results achieved from our Phase 2b study in ABSSSI. These recent data, taken in aggregate, are what various actively engaged pharmaceutical companies have desired from us for some time—and they are what triggered a newfound flurry of inbound partnership discussions at the San Francisco conferences,” commented Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals. “Datasets now in hand, reflecting three successfully completed Phase 2 studies across which multiple endpoints were met, have brought the Company to an important inflection point regarding Brilacidin. In coming weeks, we look forward to advancing these discussions with attractive partnership / licensing scenarios, towards determining the best path forward for the Company and its loyal shareholders.”
Maybe .40? Or a quick quarter? This sled dud!! It’s just crazy to think that a company with 3 blockbuster drugs with a perfect resume in 8 trials is sledding down to a quarter! Oh my!!! What a world!!!
This message is pure sarcasm.
Bullshit. Pharm has money and slot of it. Big science pays. And IPIX has big science. Mega deal and partner with friends of Art. Coming soon
You want 200 million a couple years ago and by now a RS.?!?! And then debt and cd’s? That’s a biotech world.
I think IPIX is just fine. I think there is a big phish Pharma that has been drinking wine with Leo for years. Inflection point/watershed moment is upon us. IPIX played this perfectly and has told us each move the entire way. It’s pay day - period.
The negativity here has been pushed and played brilliantly. It will all end soon
Watershed
There are a lot of Kong’s just waiting it out. And when the first deal hits and retail sells....the baker bros and the rest of the big boys will eat up and lock up 80% of the OS IMO.
Can’t wait for this day and year we move to the big board. With this pipeline it will be forever on the incline
I’m feeling a mega structured B deal. MEGA. 3 months. By April
There are options to go alone. The reason imo we sit with no pr or pumping is because our partner is picked and the final arrangements are being worked.
If I’m wrong, I’ll own up. But I’m not.
You’ll see a deal in the next 3 months. Guaranteed.
In that time you will see maybe 50K drip to Aspire.
There is plenty of cash on hand to pay the bills and salary for that time.
Again. I’ll own it if I’m wrong. But I am not wrong.
The financials are wonderful. No huge debt. They own all IP and patents to pipeline with a few % here and there for K and B but P is all IPIX.
Science is solid.
Share price means nothing.
The calculations in estimations of a product have zero to do with share price in the equation. That is a fact Dunn
What are your thoughts on that?
No new blogs.
No new trials.
Extremely limited Aspire tapping.
It’s almost like.....what are they doing? <wink>
Phase 1 safety trial then happened. It took 2-3 years? The data from there showed we need to go Oral. Now if these final safety data on Oral are good...I think it starts the excitement and we move forward on all fronts with a major partner. Pfizer.
False. You always twist everything to the negative. That seems like a pattern with you and several others. Why? Please let me know why one twists facts into a negative....over and over and over?
IMO you are a simple retail flipper. But others like DUD who post dribble more than yourself is part of something bigger.
Leo clarified that they would need to do a simple phase 1a with oral for safety. Healthy patients. Very quick and then after the cross they pick up in phase 2 or 2b. All the preclinical and clinical work is not a waste!!!!! At all! K Oral is still K. The MoA in earlier trials is so important and will lead to a major collaboration. Not a waste. That is ignorant to say.
“Research by BIDMC combined Kevetrin™ with sunitinib on cell line 786, a drug-resistant renal cancer. Cellceutix was advised by the researchers that “the Kevetrin/sunitinib combination is the first we’ve used in which actual tumor shrinkage is noted.”